113 related articles for article (PubMed ID: 35289275)
1. Potential biomarkers and the molecular mechanism associated with DLL4 during renal cell carcinoma progression.
Wang X; Zhang J; Wang Y; Wang Y; Yu W; Shi G
Am J Med Sci; 2022 Aug; 364(2):220-228. PubMed ID: 35289275
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
Huang QB; Ma X; Li HZ; Ai Q; Liu SW; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Zhang X
Oncotarget; 2014 May; 5(10):3066-75. PubMed ID: 24931473
[TBL] [Abstract][Full Text] [Related]
3. Upregulated
Wang X; Zhang J; Wang Y; Tu M; Wang Y; Shi G
Onco Targets Ther; 2018; 11():1697-1706. PubMed ID: 29618931
[TBL] [Abstract][Full Text] [Related]
4. Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4.
Huang QB; Ma X; Zhang X; Liu SW; Ai Q; Shi TP; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Li HZ; Zheng T
PLoS One; 2013; 8(6):e67294. PubMed ID: 23826258
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
Wu F; Wu S; Gou X
Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
[TBL] [Abstract][Full Text] [Related]
6. Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.
Hu GH; Liu H; Lai P; Guo ZF; Xu L; Yao XD; Zheng JH; Liu M; Xu YF
Int J Clin Exp Pathol; 2014; 7(5):2143-52. PubMed ID: 24966922
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.
Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z
Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-384-5p Promotes Endothelial Progenitor Cell Proliferation and Angiogenesis in Cerebral Ischemic Stroke through the Delta-Likeligand 4-Mediated Notch Signaling Pathway.
Fan J; Xu W; Nan S; Chang M; Zhang Y
Cerebrovasc Dis; 2020; 49(1):39-54. PubMed ID: 31927543
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis.
Zhang G; Wang J; Tan W; Han X; Han B; Wang H; Xia Y; Sun Y; Li H
Acta Histochem; 2021 Sep; 123(6):151752. PubMed ID: 34274607
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
Lin L; Cai J
J Cell Biochem; 2020 Nov; 121(11):4377-4385. PubMed ID: 31904147
[TBL] [Abstract][Full Text] [Related]
11. Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts.
Miles KM; Seshadri M; Ciamporcero E; Adelaiye R; Gillard B; Sotomayor P; Attwood K; Shen L; Conroy D; Kuhnert F; Lalani AS; Thurston G; Pili R
PLoS One; 2014; 9(11):e112371. PubMed ID: 25393540
[TBL] [Abstract][Full Text] [Related]
12. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
13. YAP Promotes VEGFA Expression and Tumor Angiogenesis Though Gli2 in Human Renal Cell Carcinoma.
Xu S; Zhang H; Chong Y; Guan B; Guo P
Arch Med Res; 2019 May; 50(4):225-233. PubMed ID: 31518897
[TBL] [Abstract][Full Text] [Related]
14. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
15. Screening of feature genes of the renal cell carcinoma with DNA microarray.
Feng JY; Diao XW; Fan MQ; Wang PX; Xiao Y; Zhong X; Wu RH; Huang CB
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):2994-3001. PubMed ID: 24302177
[TBL] [Abstract][Full Text] [Related]
16. Identification of key genes and pathways in renal cell carcinoma through expression profiling data.
Liu X; Wang J; Sun G
Kidney Blood Press Res; 2015; 40(3):288-97. PubMed ID: 26043775
[TBL] [Abstract][Full Text] [Related]
17. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
18. Integrated Analysis of miRNAs and Gene Expression Profiles Reveals Potential Biomarkers for Osteoarthritis.
Li Z; Chen Z; Wang X; Li Z; Sun H; Wei J; Zeng X; Cao X; Wan C
Front Genet; 2022; 13():814645. PubMed ID: 35783271
[No Abstract] [Full Text] [Related]
19. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
20. Systematic large-scale meta-analysis identifies miRNA-429/200a/b and miRNA-141/200c clusters as biomarkers for necrotizing enterocolitis in newborn.
Liu H; Wang YB
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31383782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]